Tecogalan sodium

DRUG4 trials

Sponsors

Daiichi Pharmaceuticals

Conditions

HIV InfectionsSarcoma, Kaposi

Phase 1

A Study of Tecogalan Sodium

CompletedNCT00002342

Daiichi PharmaceuticalsHIV Infections, Sarcoma, Kaposi

Updated: 2005-06-24

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.

CompletedNCT00002138

Daiichi PharmaceuticalsHIV Infections, Sarcoma, Kaposi

Updated: 2005-06-24

A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days

CompletedNCT00002136

Daiichi PharmaceuticalsHIV Infections, Sarcoma, Kaposi

Updated: 2005-06-24

A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4

CompletedNCT00002137

Daiichi PharmaceuticalsHIV Infections, Sarcoma, Kaposi

Updated: 2005-06-24